相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome-scale analysis of aberrant DNA methylation in colorectal cancer
Toshinori Hinoue et al.
GENOME RESEARCH (2012)
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
Annemijn M. Algra et al.
LANCET ONCOLOGY (2012)
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation
Dianren Xia et al.
NATURE MEDICINE (2012)
Aspirin Use, Body Mass Index, Physical Activity, Plasma C-Peptide, and Colon Cancer Risk in US Health Professionals
Xuehong Zhang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
C-reactive Protein and Risk of Colorectal Adenoma According to Celecoxib Treatment
Andrew T. Chan et al.
CANCER PREVENTION RESEARCH (2011)
A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis
John Burn et al.
CANCER PREVENTION RESEARCH (2011)
COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
Yuki Nakanishi et al.
CARCINOGENESIS (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence
Kyung-Hwa Lee et al.
LANGENBECKS ARCHIVES OF SURGERY (2011)
Molecular mechanisms of cancer development in obesity
Melin J. Khandekar et al.
NATURE REVIEWS CANCER (2011)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Obesity Is an Independent Prognostic Variable in Colon Cancer Survivors
Frank A. Sinicrope et al.
CLINICAL CANCER RESEARCH (2010)
Primary Prevention of Colorectal Cancer
Andrew T. Chan et al.
GASTROENTEROLOGY (2010)
Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
Farhat V. N. Din et al.
GUT (2010)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Cyclooxygenase Inhibitors, Aspirin and Ibuprofen, Inhibit MHC-restricted Antigen Presentation in Dendritic Cells
Hyun-Jin Kim et al.
Immune Network (2010)
Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence-Data from a Randomized Clinical Trial
Elizabeth L. Barry et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
Monica M. Bertagnolli et al.
CANCER PREVENTION RESEARCH (2009)
Chronic nonsteroidal anti-inflammatory drug (NSAID) use suppresses multiple CpG islands hyper methylation (CIHM) of tumor suppressor genes in the human gastric mucosa
Tomomitsu Tahara et al.
CANCER SCIENCE (2009)
Aspirin Use and Survival After Diagnosis of Colorectal Cancer
Andrew T. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients
Susanna Mandruzzato et al.
JOURNAL OF IMMUNOLOGY (2009)
The Immune Tolerance of Cancer is Mediated by IDO That is Inhibited by COX-2 Inhibitors Through Regulatory T Cells
Sling Yong Lee et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Efficacy of Meloxicam in a Patient With Juvenile Polyposis Syndrome
Francesca Mangiantini et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2009)
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
Jack Cuzick et al.
LANCET ONCOLOGY (2009)
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer
Linda A. Feagins et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
R. E. Harris
INFLAMMOPHARMACOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
Ludovic Barault et al.
CANCER RESEARCH (2008)
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials - The cross trial safety analysis
Scott D. Solomon et al.
CIRCULATION (2008)
Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2008)
Aspirin and folic acid for the prevention of recurrent colorectal adenomas
Richard F. A. Logan et al.
GASTROENTEROLOGY (2008)
Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression
Jennifer K. Colby et al.
NEOPLASIA (2008)
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Lanlan Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The frequency and suppressor function of CD4+CD25high Foxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck
Laura Strauss et al.
CLINICAL CANCER RESEARCH (2007)
Colon cancer family registry: An international resource for studies of the genetic epidemiology of colon cancer
Polly A. Newcomb et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
David Bacman et al.
BMC CANCER (2007)
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2
Andrew T. Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
James E. Talmadge et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer
Martha L. Slattery et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas
John A. Baron et al.
GASTROENTEROLOGY (2006)
Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States)
Sangmi Kim et al.
CANCER CAUSES & CONTROL (2006)
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis
David T. Rubin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Urine PGE-M:: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia
J. Chad Johnson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk
Qiuyin Cai et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Effect of Celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas
Scott D. Solomon et al.
CIRCULATION (2006)
Celecoxib for the prevention of colorectal adenomatous polyps
Nadir Arber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Celecoxib for the prevention of sporadic colorectal adenomas
Monica M. Bertagnolli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: Role of IDO
Gargi D Basu et al.
JOURNAL OF IMMUNOLOGY (2006)
The gastrointestinal safety and effect on disease activity of etoricoxib, a selective Cox-2 inhibitor in inflammatory bowel diseases
Y El Miedany et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
5-aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study
TP van Staa et al.
GUT (2005)
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease
N Kundu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study
DJ Graham et al.
LANCET (2005)
Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings
M Della Porta et al.
ONCOLOGY (2005)
Epigenetic changes in colorectal cancer
Y Kondo et al.
CANCER AND METASTASIS REVIEWS (2004)
Combination of a poxvirus-based vaccine with a cyclooxygenase-2 inhibitor (Celecoxib) elicits antitumor immunity and long-term survival in CEA.Tg/MIN mice
HE Zeytin et al.
CANCER RESEARCH (2004)
Modulation by celecoxib and difluoromethylornithine of the methylation of DNA and the estrogen receptor-α gene in rat colon tumors
MA Pereira et al.
CARCINOGENESIS (2004)
Review article: the data supporting a role for aminosalicylates in the chemoprevention of colorectal cancer in patients with inflammatory bowel disease
J Eaden
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial
R Benamouzig et al.
GASTROENTEROLOGY (2003)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
RS Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Preoperative natural killer cell activity as a prognostic factor for distant metastasis following surgery for colon cancer
E Kondo et al.
DIGESTIVE SURGERY (2003)
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
A Mantovani et al.
TRENDS IN IMMUNOLOGY (2002)
Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid
CN Bernstein et al.
INFLAMMATORY BOWEL DISEASES (2002)
Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
M Sonoshita et al.
NATURE MEDICINE (2001)
Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice
CH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
G Steinbach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Host cyclooxygenase-2 modulates carcinoma growth
CS Williams et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
